Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Thoracic Cancer|September 14, 2022
MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLCLogan C Tyler, Anh T Le, Nan Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Framework for statistical parametric mapping of the interactions between glioblastoma location, treatment, prognostic variables, and survival using a phase III trialFrancesco Sanvito, Catalina Raymond, Donatello Telesca, et al.
European Journal of Cancer (Oxford, England : 1990)|November 10, 2019
Health-related quality of life in patients with fully resected BRAF<sup>V600</sup> mutation-positive melanoma receiving adjuvant vemurafenibDirk Schadendorf, Anna Maria Di Giacomo, Lev Demidov, et al.
Molecular Oncology|March 26, 2022
Pre- and post-treatment blood-based genomic landscape of patients with ROS1 or NTRK fusion-positive solid tumours treated with entrectinibRafal Dziadziuszko, Tiffany Hung, Kun Wang, et al.
Journal of Clinical Microbiology|November 10, 2017
Laboratory Focus on Improving the Culture of Biosafety: Statewide Risk Assessment of Clinical Laboratories That Process Specimens for Microbiologic AnalysisErik Munson, Erin J Bowles, Richard Dern, et al.
WMJ : Official Publication of the State Medical Society of Wisconsin|April 9, 2016
Surveillance of Wisconsin Antibacterial Susceptibility PatternsErik Munson, Timothy K Block, Erin J Bowles, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2022
Sex-specific splicing of Z- and W-borne <i>nr5a1</i> alleles suggests sex determination is controlled by chromosome conformationXiuwen Zhang, Susan Wagner, Clare E Holleley, et al.
Frontiers in Plant Science|May 21, 2020
Complex Trait Loci in Maize Enabled by CRISPR-Cas9 Mediated Gene InsertionHuirong Gao, Jasdeep Mutti, Joshua K Young, et al.
The Pediatric Infectious Disease Journal|September 14, 2004
The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestationBarbara J Law, Joanne M Langley, Upton Allen, et al.
The Lancet. Oncology|December 16, 2019
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trialsAlexander Drilon, Salvatore Siena, Rafal Dziadziuszko, et al.
Pageof 9